Resonance Health (ASX:RHT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Resonance Health (ASX:RHT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4G & Corporate Governance Statement
FY26 Full Year Results & Investor Webinar
Resonance Health reports record FY26 revenue and returns to profitability, raises FY27 guidance
FY26 Full Year Results & FY27 Guidance Investor Presentation
Resonance Health FY26 results show 42% revenue growth, return to profit, strong cashflow, and positive FY27 outlook
Appendix 4E, Full Year Statutory Accounts & Annual Report
Resonance Health reports $1.5M profit and 42% revenue growth in FY26, driven by clinical trial and imaging software expansion
FY26 Full Year Results Webinar
Resonance Health to announce FY26 results and host investor webinar on 28 August 2026
Cessation of Quarterly Reporting
Quarterly Activities/Appendix 4C Cash Flow Report
Resonance Health reports FY26 positive cash flow, clinical trial completion, and strong contract pipeline
Change of Director's Interest Notice - Simon Panton